Skip to main content
Peter Friedmann, MD, Psychiatry, Springfield, MA

PeterDFriedmannMD

Psychiatry Springfield, MA

Addiction

Professor, Medicine, Brown University Program in Medicine

Dr. Friedmann is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Friedmann's full profile

Already have an account?

  • Office

    11 Wilbraham Rd
    Springfield, MA 01109
    Phone+1 413-794-3710
    Fax+1 413-794-9595

Education & Training

  • Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)
    Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 1988 - 1991
  • Boston University School of Medicine
    Boston University School of MedicineClass of 1988

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1992 - 2025
  • NH State Medical License
    NH State Medical License 2020 - 2024
  • VT State Medical License
    VT State Medical License 2020 - 2024
  • RI State Medical License
    RI State Medical License 1999 - 2020
  • IL State Medical License
    IL State Medical License 1994 - 1999
  • NY State Medical License
    NY State Medical License 1989 - 1992
  • American Board of Internal Medicine Internal Medicine
  • American Board of Preventive Medicine Addiction Medicine

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Improving Release Process and Treatment After Incarceration May Reduce Opioid Overdoses
    Improving Release Process and Treatment After Incarceration May Reduce Opioid OverdosesAugust 11th, 2022
  • Study: Opioid Addiction Treatment in Jail Reduces Re-Arrest Risk After Release
    Study: Opioid Addiction Treatment in Jail Reduces Re-Arrest Risk After ReleaseJanuary 19th, 2022
  • Offering Buprenorphine Medication to People with Opioid Use Disorder in Jail May Reduce Rearrest and Reconviction
    Offering Buprenorphine Medication to People with Opioid Use Disorder in Jail May Reduce Rearrest and ReconvictionJanuary 18th, 2022
  • Join now to see all

Grant Support

  • Continuum Of Care For Drug-Involved OffendersNational Institute On Drug Abuse2009–2012
  • Treatment Study Using Depot Naltrexone(2/6)Rhode Island Protocol Treatment SiteNational Institute On Drug Abuse2008–2012
  • Pilot Study Of Depot Naltrexone In Alcohol-Dependent, Homeless VeteransVeterans Affairs2011
  • Stabilize Addiction/Affect, Begin Inmates'Interferon For HCV Of Liver (STAABIHL)National Institute On Drug Abuse2007–2009
  • Continuity Of Care For Drug-Addicted Offenders In RINational Institute On Drug Abuse2004–2007
  • Trazodone For Sleep Disturbance - Early Alcohol RecoveryNational Institute On Alcohol Abuse And Alcoholism2004
  • Continuity Of Care For Drug-Addicted Offenders In RINational Institute On Drug Abuse2002–2003
  • Trazodone For Sleep Disturbance - Early Alcohol RecoveryNational Institute On Alcohol Abuse And Alcoholism2002–2003
  • Linkage To Health Services In Drug Abuse TreatmentNational Institute On Drug Abuse2000–2002
  • Trazodone For Sleep Disturbance--Early Alcohol RecoveryNational Institute On Alcohol Abuse And Alcoholism2001
  • Linkages To Primary Care In Drug Treatment ProgramsNational Institute On Drug Abuse1998–2000
  • Linkages To Primary Care In Drug Treatment ProgramsNational Institute On Drug Abuse1996–1998

Professional Memberships